New Quantics Blog: Making the most of your #Bioassay Control Wells Read it here: buff.ly/3zawUbK We're kicking off the autumn with a #blog looking at control wells! Did you know you could be utilising them to your advantage?  #biostatistics #drugdevelopment #statistics

Don't forget to book your place on our next open bioassay training course! Sign-up Here: buff.ly/3WDuiLk It's just over a month to go, so be sure to book your spot before it's too late. #bioassay #biostatistics #drugdevelopment #training #course

NEW #BLOG: Using Statistical Process Control for Bioassays Read it here: buff.ly/4gpJEfz We take a look at some of the ideas behind statistical #process control, and examine how you might set up SPC for your #bioassay. #statistics #biostatistics #drugdevelopment #spc

Are you at #CHI's #Immmunogenicity & #Bioassay Summit this week? Be sure to catch Matthew's #talk! ⏰ 10/18, 11:30am EDT 📝 Key Statistical Considerations in Interpreting #USP General Chapter <1033> 🙍‍♂️ Dr Matthew Stephenson #biostatistics #bioassay #immunogenicity #statistics

Don't forget to book your place on our upcoming bioassay statistics training #course! Book now: buff.ly/3WDuiLk Whether you are new to the subject or looking to enhance your skills, our #training is perfect for you! #bioassay #biostatistics #statistics #drugdevelopment

We asked Zeban Kohlen to describe why a change in software was right for them. Read our full conversation with Byondis here: buff.ly/3BW9cRS #biostatistics #bioassay #software #drugdevelopment #clinicaltrials #GxP #assay #potency #ELISA

Our bioassay statistics training course is just a couple weeks away! Book your place now to avoid missing out! Book here: buff.ly/3WDuiLk #bioassay #biostatistics #statistics #drugdevelopment #training #course

LAST CHANCE TO REGISTER! Don't miss out on your chance to attend our open bioassay training course: buff.ly/45o4BlW November 5th-6th 2024 #bioassay #biostatistics #drugdevelopment #training #course

We asked Zeban Kolen to outline how QuBAS is used throughout the bioassay lifecycle at Byondis. Read our full conversation with Byondis here: buff.ly/3BW9cRS #biostatistics #bioassay #software #drugdevelopment #clinicaltrials #GxP #assay #potency #ELISA

NEW Blog Post: Examining the Three-Parameter Logistic (3PL) curve for Bioassay Modelling Read here: buff.ly/3NLI0rl We discuss alternative solutions to the problems the 3PL model appears to solve. #biostatistics #bioassay #statistics #drugdevelopment #assay #blog

We asked Zeban Kolen to outline what were the main factors which drew Byondis to QuBAS. Read our full conversation with Byondis here: buff.ly/3BW9cRS #biostatistics #bioassay #software #drugdevelopment #clinicaltrials #GxP #assay #potency #ELISA

We asked Sanne Gijsbers about how QuBAS has impacted day-to-day work at Byondis. Read our full conversation with Byondis here: buff.ly/3BW9cRS #biostatistics #bioassay #software #drugdevelopment #clinicaltrials #GxP #assay #potency #ELISA

Zeban Kolen describes how Byondis use QuBAS' Interpolation Analysis mode, including the unique BY method. Read our full conversation with Byondis here: buff.ly/3BW9cRS #biostatistics #bioassay #software #drugdevelopment #clinicaltrials #GxP #assay #potency #ELISA

We asked Sanne Gijsbers and Zeban Kolen to discuss their recent upgrade to QuBAS 3.1. Read our full conversation with Byondis here: buff.ly/3BW9cRS #biostatistics #bioassay #software #drugdevelopment #clinicaltrials #GxP #assay #potency #ELISA

We asked Sanne Gijsbers to outline the onboarding process for new QuBAS users at Byondis. Read our full conversation with Byondis here: buff.ly/3BW9cRS #biostatistics #bioassay #software #drugdevelopment #clinicaltrials #GxP #assay #potency #ELISA

We asked Sanne Gijsbers about Byondis' interactions with QuBAS dedicated support team. Read our full conversation with Byondis here: buff.ly/3BW9cRS #biostatistics #bioassay #software #drugdevelopment #clinicaltrials #GxP #assay #potency #ELISA

We asked Sanne Gijsbers to tell us about how Byondis use their bespoke QuBAS plugins Read our full conversation with at Byondis here: buff.ly/3BW9cRS #biostatistics #bioassay #software #drugdevelopment #clinicaltrials #GxP #assay #potency #ELISA

New Blog Post! In Vitro vs In Vivo #Potency Assays: Modern #Vaccine Batch Release Read here: buff.ly/4iqQ4w1 We examine some of the challenges of in vivo batch release testing, and discuss why in vitro techniques can be superior. #bioassay #biostatistics #statistics

New Blog Post: Statistical Sample Size Calculations for Clinical Trials Read here: buff.ly/4gDS9TU To start the year, we bring you a #blog about a key topic in the world of clinical #biostatistics: the #sample #size calculation. #statistics #clinical #trial # blog

New Blog! Design of Experiments for Bioassay Optimisation Read it here: buff.ly/3EECy8x Part two of our collaboration with the team at @RoukenBio is here! We look at the ever-thorny issue of DoE for bioassays. #bioassay #biostatistics #drugdevelopment #assay #DoE